Vaccine News - Thailand Medical News

COVID-19 Vaccine: Washington University’s Nasal Vaccine Shows Preventive Effectiveness In Mice, Study Progresses To Non-Human Primates

Source: COVID-19 Vaccine Aug 22, 2020 4 years ago

COVID-19 Vaccine: Researchers from Washington University School of Medicine-St. Louis have developed a vaccine that targets the SARS-CoV-2 coronavirus and can be administered through the nose in one dose. Studies in mice models susceptible to the SARS-CoV-2 coronavirus have proven to be effective in preventing infection. The study team next plans to test the vaccine in nonhuman pri...

COVID-19 Vaccines: Pfizer And BioNTech Releases Additional Data On COVID-19 Vaccine Candidate BNT162b2 Early Study Results

Source: COVID-19 Vaccines Aug 21, 2020 4 years ago

COVID-19 Vaccines: Pfizer Inc. and BioNTech has released additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vaccine program against SARS-CoV-2, which has advanced into Phase 2/3 evaluation. The clinical data is published on a preprint server and is pending peer-review. https://www.medrxiv.org/content/10.1101/2020.08...

COVID-19 Vaccine: Washington University’s Genetically Modified Virus Based Vaccine Shows Promise In Mice And Prevents Severe Disease Progression

Source: COVID-19 Vaccine Aug 13, 2020 4 years ago

COVID-19 Vaccine: A new vaccine made from a mild virus genetically modified to carry a key gene from the SARS-CoV-2 coronavirus is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to research findings from Washington University School of Medicine in St. Louis. Co-senior author Dr Michael S. Diamond, MD, PhD, the Herbert S. Gasser Profess...

COVID-19 Vaccine: New Generation NovaVax’s NVX-CoV2373 Recombinant Particle Vaccine Shows Encouraging Results In Phase I Trial

Source: COVID-19 Vaccine Aug 10, 2020 4 years ago

COVID-19 Vaccine: Results of the phase one trial of NovaVAx’s NVX-CoV2373 recombinant nanoparticle vaccine that is manufactured at Emergent Biosolutions, was found to be well tolerated and immunogenic including inducing T-cell response and neutralization antibodies four-fold higher than the mean observed in hospitalized COVID-19 patients. Though several promising candidates are already on...

COVID-19 Vaccine: Novel Intranasal Vaccine Platform Offers Opportunities For More Effective Vaccines With Lesser Side Effects

Source: COVID-19 Vaccine Aug 09, 2020 4 years ago

COVID-19 Vaccine: Biotech and medical researchers from the University of Chicago and Duke University have created a new vaccine technology platform that allows the generation of the more effective vaccines with the fewest side effects using self-assembling peptide nanofibers tagged with antigens to prime the immune system against a potential invasion. The research findings were published ...

COVID-19 Vaccines Most Likely To be Ineffective For Obese Individuals. America Likely To Be In Trouble With Over 42 Percent Of The Population Obese!

Source: COVID-19 Vaccines Aug 07, 2020 4 years ago

COVID-19 Vaccines: As the world eagerly anticipates the arrival of a truly effective COVID-19 vaccine, it is emerging that one country is most likely to least benefit from it despite spending the most money compared to any other country in the world to secure a sufficient supply of the vaccine for its population. In the United States where more than 42 percent of its population is obese, ...

COVID-19 Vaccine: Novavax's COVID-19 Vaccine NVX-CoV2373 Phase I Trial Meets Endpoint Expectations

Source: COVID-19 Vaccine Aug 06, 2020 4 years ago

COVID-19 Vaccine: Maryland-based Novavax is yet another biopharma company reporting promising early-stage data for a potential COVID-19 vaccine. The biopharma company announced data from Phase I of its Phase I/II placebo-controlled trial of its vaccine with and without Matrix-M adjuvant. The trial was conducted in healthy adults 18 to 59 years of age. The vaccin...

COVID-19 Vaccine: Russia Announces Mass COVID-19 Vaccination Program in October Despite Lack Of Any Proper Clinical Trials!

Source: COVID-19 Vaccine Aug 04, 2020 4 years ago

COVID-19 Vaccine: Russia’s Minister for Health Mikhail Murashko announced that Russia is planning a nationwide program to vaccinate its population against COVID-19 starting in October. The vaccine has not yet completed clinical trials. Murashko indicated they would begin by vaccinating teachers and health care workers. He also told the RIA state news agency that while in t...

BREAKTHROUGH! COVID-19 Vaccines: ImmunityBio Inc. And Icahn Develop Next Generation Bivalent hAd5 Vaccine That Elicits Rapid T-Cell And Antibody Response

Source: COVID-19 Vaccines Aug 03, 2020 4 years ago

COVID-19 Vaccines: American researchers from ImmunityBio Inc. and Icahn School of Medicine at Mount Sinai in New York have developed a next generation COVID-19 vaccine: the bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against the SARS-CoV-2 coronavirus, using both an S protein sequence optimized for cell surface expression...

COVID-19 Vaccines: Study Shows Moderna’s mRNA-1273 Development Stage Vaccine Protects Upper And Lower Airways In Nonhuman Primates

Source: COVID-19 Vaccines Jul 29, 2020 4 years ago

COVID-19 Vaccines: Research scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health report that two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2. ...

COVID-19 Vaccine News: US-Based Dynavax Partners With Taiwan’s Medigen To Develop New Adjuvanted COVID-19 Vaccine

Source: COVID-19 Vaccine News Jul 26, 2020 4 years ago

COVID-19 Vaccine News: Dynavax Technologies, a fully-integrated biopharmaceutical based in California has partnered with Taiwan-based Medigen Vaccine Biologics to develop a new adjuvanted Covid-19 vaccine candidate. The new collaborative vaccine development will leverage on Medigen’s stable prefusion form of the SARS-CoV2 recombinant spike protein in combination with Dynavax&rs...

COVID-19 Vaccine: Arcturus Therapeutics And Duke-NUS Medical School’s LUNAR-COV19 Vaccine Secures Approval For Clinical Trials In Singapore

Source: COVID-19 Vaccine Jul 23, 2020 4 years ago

COVID-19 Vaccine: California based Arcturus Therapeutics Holdings Inc., a clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, announced that the Clinical Trial Application for COVID-19 vaccine ...

COVID-19 Vaccine Progress: BioNTech And Pfizer’s BNT162b1 RNA-Based Vaccine Elicits T Cell And Neutralizing Antibodies Response In Phase 1/2 Trial

Source: COVID-19 Vaccine Progress Jul 22, 2020 4 years ago

COVID-19 Vaccine Progress: The Phase ½ clinical trial of BioNTech And Pfizer’s BNT162b1 RNA-Based Vaccine has demonstrated that the vaccine is able to elicit both T Cell And Neutralizing Antibodies Response. The trial results were published by researchers from Germany and the United States on a preprint server and are yet to have been peer-reviewed. https://www.medrxiv.org/co...

COVID-19 Vaccine: Phase I/II Of Oxford University And AstraZenaca’s ChAdOx1 Vaccine Produces Strong Immune Response, Early Results Show

Source: COVID-19 Vaccine Updates Jul 21, 2020 4 years ago

COVID-19 Vaccine Updates: The clinical trial results of the Phase I/II trial of Oxford University and AstraZenaca’s ChAdOx1 nCoV-19 vaccine published in the scientific journal, The Lancet, indicate no early safety concerns and induces strong immune responses in both parts of the immune system. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext The ChA...

COVID-19 Vaccine: Chinese Ad5 Vectored COVID-19 Vaccine Progresses To Phase 3 As Phase 2 Trial Results Claim To Be Safe and Induces Immune Response

Source: COVID-19 Vaccine Jul 21, 2020 4 years ago

COVID-19 Vaccine: The phase 2 trial of China’s Ad5 vectored COVID-19 vaccine candidate that was conducted in Wuhan has found that the vaccine is safe and induces an immune response, according to trial findings published in The Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext#%20 The phase 2 randomized trial sought to evaluate the ...

BREAKING! COVID-19 Vaccine: As Chinese Vaccine Developer Sinopharm Starts Phase 3 Trial In Abu Dhabi, Angry Devout Muslims Are Asking How Halal Are These Vaccines?

Source: COVID-19 Vaccine Jul 19, 2020 4 years ago

COVID-19 Vaccine: It was announced that the First Phase-III clinical trial of Chinese state-owned pharmaceutical company Sinopharm's inactivated Covid-19 vaccine has started in Abu Dhabi. Head of Abu Dhabi’s health department becomes first volunteer for Covid-19 Phase III Chinese vaccine trials Interestingly the UAE health authorities recently issued a permit for up to 15,000 vo...

COVID-19 Vaccine: Moderna’s mRNA 1273 Vaccine Progresses To Phase III After Successful Early Clinical Results

Source: COVID-19 Vaccine Jul 17, 2020 4 years ago

COVID-19 Vaccine: Moderna has announced that said its COVID-19 vaccine candidate mRNA-1273 will advance to a 30,000-participant Phase III trial later this month, following publication of additional positive Phase I data from a study led by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID). The “COVE” Phase III study (NCT04470427) is expected to begin regis...

COVID-19 Vaccine Updates: Astrazeneca's COVID-19 Vaccine Performs Well In Phase 1 Trial, Generating Antibodies And T-Cells Against SARS-Cov-2

Source: COVID-19 Vaccine Jul 17, 2020 4 years ago

COVID-19 Vaccine Updates: Data from the Phase 1 trial of COVID-19 vaccine by AstraZeneca and Oxford University’s Jenner Institute is showing a robust defense against the novel coronavirus that has infected more than 13.6 million individuals across the globe U.K. media yesterday began to report hints of data from the early-stage study of the vaccine candidate...

COVID-19 Vaccine: US NIH Study On Experimental COVID-19 Vaccine mRNA-1273 Claims To Show Safe Immune Response

Source: COVID-19 Vaccine Jul 15, 2020 4 years ago

COVID-19 Vaccine: The Phase 1 trial of an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes COVID-19 disease, was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to US NIH authorities. The interim results of the trial were published yesterday in The New England Journal of Medicine....

COVID-19 Vaccine: Canadian Biopharmaceutical Company Medicago Launches Phase I Trial for Plant-Derived COVID-19 Vaccine Candidate

Source: COVID-19 Vaccine Jul 15, 2020 4 years ago

COVID- 19 Vaccine: Canadian biophamaceutical company Medicago that is based in Quebec with branches in the U.S. announced that it has begun Phase I clinical trial for its plant-derived COVID-19 vaccine candidate. It has already administered the first doses of the candidate in healthy human subjects, and the company intends to initiate a Phase II/III trial this coming October. Dr Nath...

BREAKING! COVID-19 Vaccine: New Discovery About SARS-CoV-2 Cold Sensitivity For Survival Adaptivity Could Impact Vaccine Studies And Developments

Source: COVID-19 Vaccine Jul 15, 2020 4 years ago

COVID-19 Vaccine: American researchers from Duke University-Durham have made an important discovery about the spike protein SARS-CoV-2 that could have a broad impact on vaccine studies. The S or spike protein is the structure that binds to host cell angiotensin-converting enzyme 2 (ACE2) to enable viral attachment and entry during the infection process. The spike protein is also...

MUST READ! COVID-19 Vaccine: Researchers Warn Rush To Develop Vaccine Could Backfire.Dangerous Antibody-Dependent Enhancement (ADE) Could Occur

Source: COVID-19 Vaccine Jul 14, 2020 4 years ago

COVID-19 Vaccine: There are more than 140 SARS-CoV-2 vaccines in development and the race for a successful candidate to help prevent COVID-19 is making many researchers jumpstart processes and in some cases even by pass safety protocols. Although an effective and safe vaccine would be a major advance in the fight against COVID-19, there are challenges in evaluating the efficacy of&nb...

COVID-19 Vaccine: Pre Clinical Testing Of Altimmune’s AdCOVID Intranasal Vaccine At University Of Alabama Birmingham Shows Positive Results

Source: COVID-19 Vaccine Jul 13, 2020 4 years ago

COVID-19 Vaccine: Maryland based Altimmune, Inc., a clinical-stage biopharmaceutical company, has reported positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID. The research studies; a collaboration between the University of Alabama-Birmingham and Altimmune showed strong serum neutr...

COVID-19 Vaccines: NIAID Creates Clinical Trials Network As Vaccine Trials Nationwide Facing Problems Getting Volunteers Or Patients To Enroll

Source: COVID-19 Vaccines Jul 10, 2020 4 years ago

COVID-19 Vaccines: The U.S.National Institute of Allergy & Infectious Diseases (NIAID) has founded a new clinical trials network focused on enrolling volunteers in clinical trials for COVID-19 vaccines and monoclonal antibodies. Various media have recently reported that sponsor companies are struggling to enroll patients in clinical trials for COVID-19 va...

COVID-19 Vaccine Updates: Novavax Secures US$1.6 Billion in “Warp Speed” Funding, To Start Production Of 100 Million Doses of NVX-CoV2373 Vaccine

Source: COVID-19 Vaccine Updates Jul 08, 2020 4 years ago

COVID-19 Vaccine Updates: Maryland based Biotech company Novavax announced that it has been awarded US$1.6 billion toward late-stage clinical trials and large-scale manufacturing to produce 100 million doses of its COVID-19 vaccine starting this year through the Trump’s administration “Operation Warp Speed” program. The new funding will enable Novavax to complete la...

COVID-19 Vaccine News: Johnson And Johnson Contracts Emergent BioSolutions For 5 Year, I Billion Doses Of Ad26.COV2-S Vaccine Manufacturing Deal

Source: COVID-19 Vaccine News Jul 07, 2020 4 years ago

COVID-19 Vaccine News: Biotech manufacturing company-Emergent BioSolutions, based in Maryland, entered a five-year manufacturing services deal with Janssen Pharmaceutical, a Johnson & Johnson company, to manufacture J&J’s Ad26.COV2-S COVID-19 vaccine. Emergent will handle contract development and manufacturing (CDMO) services in a deal that is valued at ...

COVID-19 Vaccine Updates: South Australia’s Flinders University Commences Phase 1 Trial Of COVID-19 Vaccine COVAX-19 Developed By Vaxine Pty Ltd

Source: COVID-19 Vaccine Updates Jul 07, 2020 4 years ago

COVID-19 Vaccine Updates: It was announced that vaccine candidate COVAX-19 developed by Vaxine Pty Ltd and Flinders University will commence Phase 1 trials at the Royal Adelaide Hospital (RAH) to test its efficacy. The phase I trial will provide initial safety and immune response data on 40 healthy participants aged between 18 and 65 years who have already been pre-screened. Resear...

COVID-19 Vaccine: Oxford’s and AstraZenaca’s ChAdOx1 Vaccine Progresses Into Phase III Human Trials

Source: COVID-19 Vaccine Jul 06, 2020 4 years ago

COVID-19 Vaccine: Professor of vaccinology at the University of Oxford, and one of the scientists leading the vaccine initiative, Dr Sarah Gilbert, told the U.K.'s Science and Technology Committee last week that their candidate vaccine has progressed to the phase III trial in the United Kingdom. Phase III trials typically involves tens of thousands of research participants acros...

COVID-19 Vaccine: China Creates Artificial Protein That Can Be Basis For Broad-Spectrum Vaccine While Others Warn Vaccines Might Not Be Effective Long Term

Source: COVID-19 Vaccine Jul 05, 2020 4 years ago

COVID-19 Vaccine: Researchers from China have created an artificial protein that they say could be the basis of a vaccine to help ward off various deadly coronaviruses, including the pathogen that causes Covid-19 Copyright: Credit: Xinhua The researchers from the Chinese CDC said the approach triggered a strong antibody response in mice and monkey trials to Middle Eas...

COVID-19 Vaccine: India’s Second COVID-19 Vaccine By Zydus Cadila Gets Approval For Human Trials

Source: COVID-19 Vaccine Jul 04, 2020 4 years ago

COVID-19 Vaccine: Indian pharmaceutical company, Zydus Cadila received the green signal from the Drug Controller General of India (DGCI) to start phase I and II of their clinical trials on human participants. Over 120 independent scientific bodies are in contention to find a potential COVID-19 vaccine. Over 7 vaccines are being researched in India and just this week, two candidate groups ...

COVID-19 Vaccine Updates - Pfizer and BioNTech Publish Positive Interim Phase I/II Data for COVID-19 Vaccine

Source: COVID-19 Vaccine Updates Jul 04, 2020 4 years ago

COVID-19 Vaccine Updates: Pharmaceutical and Biotech giants, Pfizer and BioNTech reported that the most advanced of four constructs of their messenger RNA (mRNA) vaccine candidate for COVID-19 showed encouraging immunogenicity and a favorable safety profile in preliminary Phase I/II data published in a preprint study. https://www.medrxiv.org/content/10.1101/2020.06.30.20142570v1 Bot...

COVID-19 Vaccine: American National Institute Of Health Lays Down Prerequisites On Human Infection Models To Support SARS-CoV-2 Vaccine Development

Source: COVID-19 Vaccine Jul 02, 2020 4 years ago

COVID-19 Vaccine: Members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development. In a new report published in th...

Interesting Reads

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 4 months ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 7 months ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 11 months ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 1 year ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 1 year ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 2 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 4 years ago

BREAKING! COVID-19 Symptoms: King’s College London and Massachusetts General Hospital Identify Six Specific Symptom Cluster ‘Types’ Of COVID-19 Infections.

Source: COVID-19 Symptoms
Jul 20, 2020 4 years ago

BREAKING NEWS! COVID-19 Alert: Research Led By Cedars-Sinai Indicates That Proton Pump Inhibitors (PPIs) Use Is Linked To Increased Risk Of COVID-19

Source: COVID-19 Alert
Jul 08, 2020 4 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 4 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 4 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 4 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 4 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 4 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 4 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 4 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 4 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 4 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 4 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 4 years ago

Researchers Say One Potential Long-Term Health Implication Of COVID-19 Could Be Hearing Loss

Source: COVID-19 Long-Term Health Implications
Jun 13, 2020 4 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 4 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 4 years ago

Northwestern University Issues COVID-19 Warning That The Whole Nervous System Can Be Affected By The SARS-CoV-2 Coronavirus

Source: COVID-19 Warning
Jun 12, 2020 4 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 4 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 4 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 4 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 4 years ago

COVID-19 Research: Study From Columbia University Indicates That Lowering Testosterone Levels Could Reduce Severity Of COVID-19

Source: COVID-19 Research
Jun 08, 2020 4 years ago

Uric Acid: Japanese Researchers Discover That High Uric Acid Levels Protects Against Lung Function Decline Especially In Older Women

Source: Uric Acid Supplements
Jun 07, 2020 4 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 4 years ago

BREAKING! Studies Show Famotidine, A Common Indigestion Drug Could Help In Mild To Moderate Cases Of COVID-19

Source: Famotidine And COVID-19
Jun 05, 2020 4 years ago

BREAKING! Pediatrics: Study Indicates That Multisystem Inflammatory Syndrome More Predominant Among Children Of African Ancestry Infected With COVID-19

Source: Pediatrics
Jun 04, 2020 4 years ago

Pregnancy And COVID-19: Study Shows Choline Supplements Could Help Pregnant Women Reduce Negative Effects Of COVID-19 In Newborns

Source: Pregnancy And COVID-19
Jun 02, 2020 4 years ago

COVID-19 Research: University Of Massachusetts Study Warns Of Emerging Genomic Variants In SARS-CoV-2 Coronavirus That Could Lead To Drug Resistance

Source: COVID-19 Research
May 29, 2020 4 years ago

Covid-19: New Study Published In JAMA Says Certain COVID-19 Recovered Patients Still Test Positive Even Days After Being Discharged

Source: Covid-19
May 29, 2020 4 years ago

BREAKING! Coronavirus Latest: Louisiana State University Pathologists’ First COVID-19 Autopsy Series Reveals Cardiopulmonary Anomalies

Source: Coronavirus Latest
May 28, 2020 4 years ago

MUST READ!!! Brazilian Respiratory Expert Says That COVID-19 Should Be Treated As A Thrombotic Disease

Source: COVID-19
May 28, 2020 4 years ago

COVID-19 Research: New Study Reveals That Specific Types Of T-Cells Are Targeted By The SARS-CoV-2 Coronavirus In Patient’s Immune System

Source: COVID-19 Research
May 27, 2020 4 years ago

COVID-19 Research: Could Disulfiram- A Drug To Prevent Alcoholism, Aid In Inhibiting Cytokine Storms In COVID-19?

Source: Covid-19 Research
May 26, 2020 4 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 4 years ago

WARNING! COVID-19 Patients Could Also Develop Thyroid Infections

Source: COVID-19 News
May 21, 2020 4 years ago

COVID-19: Study Shows That COVID-19 Infections Could Lead To Delirium, PTSD and Other Psychiatric Disorders

Source: COVID-19 News
May 19, 2020 4 years ago

COVID-19 Supplements: Silymarin From Milk Thistle Could Perhaps Also Be Used As An Adjuvant Supplement To Help COVID-19 Patients

Source: COVID-19 Supplements
May 18, 2020 4 years ago

MUST READ! COVID-19 Supplements: Could Rutin Be The Secret Ingredient In China’s TCM Formulations That Helped Treat COVID-19 As Adjuvant Protocols?

Source: COVID-19 Supplements
May 15, 2020 4 years ago

COVID-19 Research: Worrying Gastrointestinal Abnormalities Revealed In Abdominal Imaging Studies Of COVID-19 Patients

Source: COVID-19 Research
May 12, 2020 4 years ago

COVID-19 Clinical Care: Kidney Failure Emerging As A Common Occurrence From COVID-19 Infections

Source: COVID-19 Clinical Care
May 12, 2020 4 years ago

MUST READ! COVID-19 Alerts: Children Are At High Risk For Critical Complications And Death From COVID-19

Source: COVID-19 Alerts
May 12, 2020 4 years ago

COVID-19 Therapeutics: Computational Screenings Show A Variety Of Natural Phytochemicals Could Have Efficacy Against SARS-CoV-2 Including EGCG From Green Tea

Source: COVID-10 Therapeutics
May 11, 2020 4 years ago

COVID-19 Drugs: Study Shows Common And Cheap Heartburn Drug Famotidine Improves Outcomes Of Hospitalized COVID-19 Patients

Source: COVID-19 Drugs
May 11, 2020 4 years ago

FROM GENOMICS AND EPIGENETICS

LATEST ON HERBS AND PHYTOCHEMICALS

Herb-Spice News: Study Shows That Cardamom Helps In Weight Loss, Liver And Mitochondria Health And Prevents Inflammation!

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

MOST READ

Interesting Reads

FROM GENOMICS AND EPIGENETICS

LATEST ON HERBS AND PHYTOCHEMICALS